-
Having the support of friends, old and new, makes all the difference
I received an overwhelming response to my last column, in which I grappled with feelings […]
-
Trial will test gene therapy for limb-girdle muscular dystrophy type
Regulators in France and Italy have given Atamyo Therapeutics the green light to launch a […]
-
Managing motherhood and caregiving: Where is the beauty?
My mind is spinning like the wheels on my son’s power wheelchair in the freshly […]
-
WATCH: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat) (Webinar Recording)
ITF Therapeutics recently joined PPMD for a webinar to provide the Duchenne community with an […]
-
Fiscal Year 2024 Appropriations Package Signed Into Law, Including Critical Funding for Duchenne and Becker
At the beginning of March, PPMD’s Advocacy Conference brought together more than 120 advocates from […]
-
Mitochondrial dysfunction may be a treatment target in DM2
In myotonic dystrophy type 2 (DM2), muscle cells have dysfunctional mitochondria, the cell’s so-called powerhouse […]
-
Managing Femur Fractures in Duchenne Muscular Dystrophy
By Jennifer Wallace, PT and Doug Levine, PT Introduction Duchenne muscular dystrophy (DMD) is a […]
-
Miami Community Comes Together for CureDuchenne, Raising Nearly $2.5M Since 2021
DJ Irie of the Miami Heat Headlines “Champions in Miami” to Help Find a Cure […]
-
Duchenne clinical trials show me how mature my sons have become
I recently took my three sons with Duchenne muscular dystrophy (DMD) to a hospital in […]
-
FDA Grants Approval to DUVYZAT™ (Givinostat)
PPMD is excited to learn that the FDA has granted approval to DUVYZAT (givinostat), a […]
